Paul Beninger

1.1k total citations
34 papers, 527 citations indexed

About

Paul Beninger is a scholar working on Toxicology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Paul Beninger has authored 34 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 9 papers in Economics and Econometrics and 8 papers in Epidemiology. Recurrent topics in Paul Beninger's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Biosimilars and Bioanalytical Methods (7 papers) and Pharmaceutical Economics and Policy (5 papers). Paul Beninger is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Biosimilars and Bioanalytical Methods (7 papers) and Pharmaceutical Economics and Policy (5 papers). Paul Beninger collaborates with scholars based in United States, France and India. Paul Beninger's co-authors include Robert G. Sharrar, Sharon P. Steinberg, Anne A. Gershon, Philip LaRussa, G K Chikami, C Roudier, Joshua Fierer, D G Guiney, Hirohiko ABE and Kyuichi Tanikawa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American Statistical Association and Gastroenterology.

In The Last Decade

Paul Beninger

31 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Beninger United States	10	195	108	73	65	59	34	527
Karen Midthun United States	16	193 1.0×	63 0.6×	512 7.0×	7 0.1×	94 1.6×	20	933
Jean Louis Ndiaye Senegal	25	207 1.1×	13 0.1×	200 2.7×	10 0.2×	28 0.5×	91	1.7k
Lena Shah Canada	15	600 3.1×	16 0.1×	534 7.3×	42 0.6×	25 0.4×	17	1.1k
Lasse S Vestergaard Denmark	26	186 1.0×	5 0.0×	314 4.3×	24 0.4×	20 0.3×	56	1.5k
Oumar Gaye Senegal	28	151 0.8×	12 0.1×	169 2.3×	3 0.0×	38 0.6×	86	2.0k
Hermann Sorgho Burkina Faso	18	95 0.5×	9 0.1×	63 0.9×	9 0.1×	22 0.4×	58	895
Arthur Mpimbaza Uganda	19	92 0.5×	4 0.0×	148 2.0×	18 0.3×	16 0.3×	52	1.1k
John R. MacArthur United States	13	89 0.5×	9 0.1×	186 2.5×	11 0.2×	11 0.2×	29	913
Aaron Mabuza South Africa	16	121 0.6×	15 0.1×	93 1.3×	5 0.1×	36 0.6×	28	790
Olugbenga Ayodeji Mokuolu Nigeria	14	162 0.8×	5 0.0×	145 2.0×	9 0.1×	15 0.3×	58	1.4k

Countries citing papers authored by Paul Beninger

Since Specialization

Citations

This map shows the geographic impact of Paul Beninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Beninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Beninger more than expected).

Fields of papers citing papers by Paul Beninger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Beninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Beninger. The network helps show where Paul Beninger may publish in the future.

Co-authorship network of co-authors of Paul Beninger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Beninger. A scholar is included among the top collaborators of Paul Beninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Beninger. Paul Beninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nguyen, Kimberly H., et al.. (2024). Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021. Vaccine. 42(7). 1617–1629. 3 indexed citations

Beninger, Paul, et al.. (2024). Generic Drugs and the Struggle to Compete: The Role of Skinny Labels. Clinical Therapeutics. 46(5). 420–423.

Beninger, Paul. (2023). Drug-Drug Interactions: How to Manage the Risk–A Stakeholder Approach. Clinical Therapeutics. 45(2). 106–116. 1 indexed citations

Marquez, Loreta, et al.. (2023). Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use. Drug Safety. 47(1). 1–22. 3 indexed citations

Nguyen, Kimberly H., et al.. (2023). COVID-19 booster vaccination coverage among adults, children and adolescents and reasons for non-receipt, United States. American Journal of Infection Control. 51(9). 1067–1071. 2 indexed citations

Nguyen, Kimberly H., et al.. (2022). Trends in vaccination schedules and up-to-date status of children 19–35 months, United States, 2015–2020. Vaccine. 41(2). 467–475. 8 indexed citations

Beninger, Paul, et al.. (2022). Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey. Clinical Therapeutics. 44(9). 1225–1236. 7 indexed citations

Nguyen, Kimberly H., et al.. (2022). Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?. American Journal of Infection Control. 50(10). 1185–1189. 13 indexed citations

Beninger, Paul. (2022). Need for a contingency dimension when planning vaccine development in a pandemic environment. Vaccine. 40(21). 2895–2896. 1 indexed citations

10.

Beninger, Paul, et al.. (2021). Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database. Clinical Therapeutics. 43(2). 380–395. 5 indexed citations

11.

Beninger, Paul. (2020). Signal Management in Pharmacovigilance: A Review of Activities and Case Studies. Clinical Therapeutics. 42(6). 1110–1129. 2 indexed citations

12.

Beninger, Paul. (2020). COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use. Clinical Therapeutics. 42(8). 1444–1450. 11 indexed citations

13.

Beninger, Paul. (2018). Civic Engagement: A Physician's Perspective. Journal of Health Politics Policy and Law. 44(1). 147–156. 3 indexed citations

14.

Beninger, Paul. (2017). Opportunities for Collaboration at the Interface of Pharmacovigilance and Manufacturing. Clinical Therapeutics. 39(4). 702–712. 12 indexed citations

15.

Beninger, Paul, et al.. (2017). Data Sharing in the Pharmaceutical Enterprise: The Genie's Out of the Bottle. Clinical Therapeutics. 39(9). 1890–1894. 3 indexed citations

16.

Beninger, Paul, et al.. (2008). The Safety Profile of Varicella Vaccine: A 10‐Year Review. The Journal of Infectious Diseases. 197(s2). S165–S169. 166 indexed citations

17.

Gould, A. Lawrence, Paul Beninger, Ryan M. Carney, et al.. (2007). An Evaluation of Computer-Aided Disproportionality Analysis for Post-Marketing Signal Detection. Clinical Pharmacology & Therapeutics. 82(2). 173–180. 23 indexed citations

18.

Beninger, Paul, et al.. (1988). Physical and genetic mapping of the Salmonella dublin virulence plasmid pSDL2. Relationship to plasmids from other Salmonella strains.. Journal of Clinical Investigation. 81(5). 1341–1347. 69 indexed citations

19.

Beninger, Paul, et al.. (1985). Survey on views and knowledge of house officers on medical-legal issues. Academic Medicine. 60(6). 481–3. 1 indexed citations

20.

Sata, Michio, et al.. (1981). . Kanzo. 22(10). 1386–1392. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact